ERBB2 and breast cancer: Zhang et al. found that emodin could act as a tyrosine kinase inhibitor to inhibit the activity of HER-2/neu tyrosine kinase in MDA-MB453 cells, inhibit the growth of cancer cells, induce the production of lipid droplets, and promote the mature differentiation of BC cells 111.